Downes, Damien J. http://orcid.org/0000-0002-5034-0869
Cross, Amy R.
Hua, Peng http://orcid.org/0000-0003-3774-5033
Roberts, Nigel http://orcid.org/0000-0002-5091-3604
Schwessinger, Ron http://orcid.org/0000-0001-7829-8503
Cutler, Antony J. http://orcid.org/0000-0002-9617-9994
Munis, Altar M. http://orcid.org/0000-0001-9218-3032
Brown, Jill http://orcid.org/0000-0002-8884-2047
Mielczarek, Olga
de Andrea, Carlos E.
Melero, Ignacio
Gill, Deborah R.
Hyde, Stephen C.
Knight, Julian C. http://orcid.org/0000-0002-0377-5536
Todd, John A. http://orcid.org/0000-0003-2740-8148
Sansom, Stephen N. http://orcid.org/0000-0003-4569-8513
Issa, Fadi http://orcid.org/0000-0002-8279-7732
Davies, James O. J. http://orcid.org/0000-0002-4108-4357
Hughes, Jim R. http://orcid.org/0000-0002-8955-7256
,
Funding for this research was provided by:
RCUK | Medical Research Council (MR/R008108, MC_UU_00016/14)
Wellcome Trust (098931/Z/12/Z, 203728/Z/16/Z, WT204969/Z/16/Z, 107212/Z/15/Z, 203141/Z/16/Z, 106130/Z/14/Z, 110579/Z/15/Z, 110579/Z/15/Z, 110579/Z/15/Z, 211122/Z/18/Z)
Oxford University Medical Science Internal Fund: Pump Priming
Chinese Academy of Medical Sciences (2018-I2M-2-002)
Juvenile Diabetes Research Foundation (4-SRA-2017-473-A-N)
Banco Bilbao Vizcaya Argentaria
Kennedy Trust for Rheumatology Research Core
Article History
Received: 23 October 2020
Accepted: 22 September 2021
First Online: 4 November 2021
Competing interests
: J.R.H. and J.O.J.D. are founders and shareholders of Nucleome Therapeutics; J.R.H., J.O.J.D., D.J.D. and R.S. are paid consultants for Nucleome Therapeutics. J.R.H. and J.O.J.D. hold patents for Capture-C (nos. WO2017068379A1, EP3365464B1 and US10934578B2) and have a patent application for MCC. J.A.T. is a member of the GSK Human Genetics Advisory Board. The other authors declare no competing interests.
Free to read: This content has been made available to all.